Cutting edge pharmaceutical production and scientific research in Cuba
To supervise clinical evaluations required to register patents, and distribute pharmaceuticals and biotechnology produced in Cuba, the National Clinical Trials Coordinating Center was established in 1991, and has been involved in more than 150 such projects over the years
Author: Nuria Barbosa León | internet@granma.cu
Author: Joaquín Rivery Tur | rivery@granma.cu
february 14, 2017 17:02:21
Director Carlos Manuel García noted that the National Clinical Trials Coordinating Center has expert staff in all provinces.
The Genetic Engineering and Biotechnology Center.
Photo: Orfilio Pelaez
Browsing the web reveals an extraordinary number of sites citing the strength of Cuba’s pharmaceutical and biotechnology industries, along with the number of countries purchasing Cuban products for their populations. Yet the corporate media makes little mention of this accomplishment.
Among the country’s most important, latest-generation medications is Heberprot P, used by more than 225,000 patients in many countries to treat diabetic foot ulcers and avoid a large percentage of amputations. It is currently administered via nano-capsules, making the drug’s anti-microbial impact very effective.
Continue reading Cutting edge pharmaceutical production and scientific research in Cuba




You must be logged in to post a comment.